Palivizumab for children with Down syndrome: is the time right for a universal recommendation? | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Editorial

Palivizumab for children with Down syndrome: is the time right for a universal recommendation?

Online download statistics by month:

Online download statistics by month: December 2018 to December 2022

	Abstract	Full	Pdf
Dec 2018	730	48	21
Jan 2019	2474	124	91
Feb 2019	300	23	16
Mar 2019	256	15	12
Apr 2019	235	9	7
May 2019	212	11	7
Jun 2019	195	6	4
Jul 2019	741	112	53
Aug 2019	299	68	38
Sep 2019	117	41	20
Oct 2019	108	18	13
Nov 2019	98	7	8
Dec 2019	76	10	5
Jan 2020	109	9	5
Feb 2020	104	11	8
Mar 2020	45	2	1
Apr 2020	64	3	3
May 2020	37	3	1
Jun 2020	71	3	4
Jul 2020	62	0	3
Aug 2020	28	2	5
Sep 2020	110	4	3
Oct 2020	84	2	1
Nov 2020	75	6	4
Dec 2020	61	2	1
Jan 2021	51	3	4
Feb 2021	55	1	2
Mar 2021	33	3	1
Apr 2021	45	4	3
May 2021	50	0	3
Jun 2021	3	0	0
Jul 2021	4	4	2
Sep 2021	4	1	0
Oct 2021	46	0	2
Nov 2021	37	1	2
Dec 2021	39	4	0
Jan 2022	48	2	2
Feb 2022	26	1	2
Mar 2022	50	3	2
Apr 2022	12	0	2
May 2022	51	0	0
Jun 2022	60	0	0
Jul 2022	67	4	1
Aug 2022	62	2	0
Sep 2022	65	2	2
Oct 2022	57	1	1
Nov 2022	51	3	2
Dec 2022	15	2	0
Total	7622	580	367